TD Cowen Maintains Buy on Tenet Healthcare, Lowers Price Target to $233

Benzinga Newsdesk www.benzinga.com Neutral 48.6%

Neg 0% Neu 48.6% Pos 0%

TD Cowen analyst Ryan Langston maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $242 to $233.